Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $76.11 billion. The enterprise value is $99.50 billion.
Important Dates
The last earnings date was Tuesday, October 21, 2025, before market open.
| Earnings Date | Oct 21, 2025 |
| Ex-Dividend Date | Dec 5, 2025 |
Share Statistics
Elevance Health has 222.24 million shares outstanding. The number of shares has decreased by -3.08% in one year.
| Current Share Class | 222.24M |
| Shares Outstanding | 222.24M |
| Shares Change (YoY) | -3.08% |
| Shares Change (QoQ) | -0.93% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 94.76% |
| Float | 221.72M |
Valuation Ratios
The trailing PE ratio is 14.04 and the forward PE ratio is 12.19. Elevance Health's PEG ratio is 13.58.
| PE Ratio | 14.04 |
| Forward PE | 12.19 |
| PS Ratio | 0.40 |
| Forward PS | 0.37 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 18.23 |
| P/FCF Ratio | 20.21 |
| P/OCF Ratio | 15.50 |
| PEG Ratio | 13.58 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.15, with an EV/FCF ratio of 26.41.
| EV / Earnings | 17.98 |
| EV / Sales | 0.51 |
| EV / EBITDA | 11.15 |
| EV / EBIT | 12.25 |
| EV / FCF | 26.41 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.56 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 3.52 |
| Debt / FCF | 8.52 |
| Interest Coverage | 5.90 |
Financial Efficiency
Return on equity (ROE) is 12.57% and return on invested capital (ROIC) is 6.89%.
| Return on Equity (ROE) | 12.57% |
| Return on Assets (ROA) | 4.24% |
| Return on Invested Capital (ROIC) | 6.89% |
| Return on Capital Employed (ROCE) | 9.92% |
| Revenue Per Employee | $1.87M |
| Profits Per Employee | $53,100 |
| Employee Count | 104,200 |
| Asset Turnover | 1.63 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.57 billion in taxes.
| Income Tax | 1.57B |
| Effective Tax Rate | 22.15% |
Stock Price Statistics
The stock price has decreased by -19.47% in the last 52 weeks. The beta is 0.59, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -19.47% |
| 50-Day Moving Average | 327.53 |
| 200-Day Moving Average | 368.41 |
| Relative Strength Index (RSI) | 52.34 |
| Average Volume (20 Days) | 1,919,312 |
Short Selling Information
The latest short interest is 2.73 million, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 2.73M |
| Short Previous Month | 3.68M |
| Short % of Shares Out | 1.23% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 1.46 |
Income Statement
In the last 12 months, Elevance Health had revenue of $194.82 billion and earned $5.53 billion in profits. Earnings per share was $24.39.
| Revenue | 194.82B |
| Gross Profit | 51.16B |
| Operating Income | 8.12B |
| Pretax Income | 7.10B |
| Net Income | 5.53B |
| EBITDA | 8.92B |
| EBIT | 8.12B |
| Earnings Per Share (EPS) | $24.39 |
Full Income StatementBalance Sheet
The company has $36.22 billion in cash and $32.10 billion in debt, giving a net cash position of -$23.39 billion or -$105.24 per share.
| Cash & Cash Equivalents | 36.22B |
| Total Debt | 32.10B |
| Net Cash | -23.39B |
| Net Cash Per Share | -$105.24 |
| Equity (Book Value) | 44.08B |
| Book Value Per Share | 197.95 |
| Working Capital | 22.90B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.91 billion and capital expenditures -$1.15 billion, giving a free cash flow of $3.77 billion.
| Operating Cash Flow | 4.91B |
| Capital Expenditures | -1.15B |
| Free Cash Flow | 3.77B |
| FCF Per Share | $16.95 |
Full Cash Flow StatementMargins
Gross margin is 26.26%, with operating and profit margins of 4.17% and 2.84%.
| Gross Margin | 26.26% |
| Operating Margin | 4.17% |
| Pretax Margin | 3.64% |
| Profit Margin | 2.84% |
| EBITDA Margin | 4.58% |
| EBIT Margin | 4.17% |
| FCF Margin | 1.93% |
Dividends & Yields
This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | $6.84 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | 4.91% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 28.05% |
| Buyback Yield | 3.08% |
| Shareholder Yield | 5.07% |
| Earnings Yield | 7.27% |
| FCF Yield | 4.95% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $391.80, which is 14.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $391.80 |
| Price Target Difference | 14.40% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 13.42% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
